Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in India

Dr. Reddy’s collaborates with Pharmazz to introduce Centhaquine as Lyfaquin in India, aiming to improve hypovolemic shock treatment. The partnership includes marketing rights for Nepal and addresses the high mortality rate in traumatic haemorrhages. Read The Rest at :